Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2019

Velu PD, Perl AE, Luger SM, Bagg A, Morrissette JJ. Longitudinal targeted next-generation sequencing in a patient with acute myeloid leukaemia. Br J Haematol. 2019;186(6):801.

Butler AE, Hayat S, Dargham SR, Malek JA, Abdulla SA, Mohamoud YA, et al. Alterations in long noncoding RNAs in women with and without polycystic ovarian syndrome. Clin Endocrinol (Oxf). 2019;91(6):793-797.

Nellis ME, Goel R, Karam O, Cushing MM, Davis PJ, Steiner ME, et al. Effects of ABO Matching of Platelet Transfusions in Critically Ill Children. Pediatr Crit Care Med. 2019;20(2):e61-e69.

Garcia-Bermudez J, Baudrier L, Bayraktar EC, Shen Y, La K, Guarecuco R, et al. Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death. Nature. 2019;567(7746):118-122.

Magro CM, Ruan J, Grossman M, Hedayat AA. Monoclonal plasma cell infiltrates in the setting of cutaneous follicular helper T cell lymphoproliferative disorders. Ann Diagn Pathol. 2019;40:94-104.

Vasovic LV, DeSimone RA. Increase in Google search interest for paid plasma donation in the United States during and after the great recession. Transfusion. 2019;59(10):3056-3057.

Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, et al. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood. 2019;133(15):1664-1676.

Evans MS, Burkhart CN, Bowers EV, Culpepper KS, Googe PB, Magro CM. Solitary plaque on the leg of a child: A report of two cases and a brief review of acral pseudolymphomatous angiokeratoma of children and unilesional mycosis fungoides. Pediatr Dermatol. 2019;36(1):e1-e5.

Lau BW, Huh K, Madero-Marroquin R, De Marchi F, Lim Y, Wang Q, et al. Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity. Oncogene. 2019;38(5):687-698.

Bartlett NL, Wilson WH, Jung S-, Hsi ED, Maurer MJ, Pederson LD, et al. Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303. J Clin Oncol. 2019;37(21):1790-1799.